Free Trial

Atom Investors LP Makes New $2.81 Million Investment in CompoSecure, Inc. (NASDAQ:CMPO)

CompoSecure logo with Business Services background

Atom Investors LP purchased a new stake in shares of CompoSecure, Inc. (NASDAQ:CMPO - Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund purchased 200,237 shares of the company's stock, valued at approximately $2,807,000. Atom Investors LP owned about 0.23% of CompoSecure at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in CMPO. Pacific Ridge Capital Partners LLC grew its stake in shares of CompoSecure by 146.9% during the second quarter. Pacific Ridge Capital Partners LLC now owns 486,462 shares of the company's stock worth $3,308,000 after buying an additional 289,451 shares during the last quarter. Renaissance Technologies LLC increased its holdings in CompoSecure by 165.4% in the 2nd quarter. Renaissance Technologies LLC now owns 209,389 shares of the company's stock worth $1,424,000 after purchasing an additional 130,489 shares in the last quarter. Bailard Inc. bought a new position in CompoSecure in the second quarter valued at about $259,000. Rhumbline Advisers boosted its stake in shares of CompoSecure by 17.3% during the second quarter. Rhumbline Advisers now owns 19,521 shares of the company's stock valued at $133,000 after purchasing an additional 2,877 shares in the last quarter. Finally, Rice Hall James & Associates LLC bought a new stake in shares of CompoSecure during the third quarter worth about $3,766,000. 37.56% of the stock is currently owned by institutional investors and hedge funds.

CompoSecure Stock Down 0.3 %

Shares of CompoSecure stock traded down $0.05 during trading hours on Tuesday, reaching $16.10. The company's stock had a trading volume of 287,315 shares, compared to its average volume of 533,957. The stock's fifty day simple moving average is $14.74 and its two-hundred day simple moving average is $10.79. CompoSecure, Inc. has a one year low of $4.61 and a one year high of $16.39.

CompoSecure (NASDAQ:CMPO - Get Free Report) last issued its quarterly earnings data on Friday, November 8th. The company reported $0.27 EPS for the quarter, missing analysts' consensus estimates of $0.29 by ($0.02). The company had revenue of $107.14 million for the quarter, compared to the consensus estimate of $105.11 million. CompoSecure had a negative return on equity of 14.87% and a negative net margin of 5.63%. During the same period in the prior year, the firm posted $0.24 earnings per share. On average, equities research analysts predict that CompoSecure, Inc. will post 1.02 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the stock. Benchmark reiterated a "buy" rating and set a $17.00 target price on shares of CompoSecure in a research report on Tuesday, November 12th. B. Riley boosted their price objective on shares of CompoSecure from $18.00 to $23.00 and gave the stock a "buy" rating in a research note on Monday, November 11th. JPMorgan Chase & Co. raised their target price on CompoSecure from $12.00 to $16.00 and gave the stock a "neutral" rating in a research report on Monday. Compass Point upped their price target on CompoSecure from $11.50 to $14.50 and gave the company a "buy" rating in a research report on Tuesday, August 20th. Finally, Bank of America raised their price objective on CompoSecure from $9.00 to $10.00 and gave the stock a "buy" rating in a research report on Thursday, August 8th. One equities research analyst has rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, CompoSecure presently has an average rating of "Moderate Buy" and a consensus price target of $16.36.

Get Our Latest Analysis on CMPO

Insiders Place Their Bets

In other news, COO Gregoire Maes sold 24,323 shares of CompoSecure stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $16.25, for a total transaction of $395,248.75. Following the sale, the chief operating officer now directly owns 762,009 shares in the company, valued at $12,382,646.25. The trade was a 3.09 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Adam Joseph Lowe sold 5,730 shares of the business's stock in a transaction dated Wednesday, September 11th. The stock was sold at an average price of $12.05, for a total transaction of $69,046.50. Following the completion of the transaction, the insider now directly owns 1,292,219 shares in the company, valued at $15,571,238.95. This trade represents a 0.44 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 10,666,590 shares of company stock valued at $80,774,821 in the last three months. 74.99% of the stock is currently owned by insiders.

CompoSecure Company Profile

(Free Report)

CompoSecure, Inc manufactures and designs metal, composite, and proprietary financial transaction cards in the United States and internationally. Its primary metal form factors include embedded, metal veneer lite, metal veneer, and full metal products. The company also offers Arculus Cold Storage Wallet, a three-factor authentication solution, which supports specific digital assets, including Bitcoin, Ethereum, non-fungible tokens and others.

Featured Articles

Institutional Ownership by Quarter for CompoSecure (NASDAQ:CMPO)

Should you invest $1,000 in CompoSecure right now?

Before you consider CompoSecure, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CompoSecure wasn't on the list.

While CompoSecure currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Former Trump Advisor: Expect REITs to Soar Under Trump’s Next Presidency
Super Micro’s Rebound: Can SMCI Stock Rally Another 100%?
Why Meta Is Still a Top Stock Pick for 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines